It suggests that both epigenetic and genetic mechanisms may play a role in regulation of GE-induced expression changes of p16 and p21 and both mechanisms may predominately regulate certain gene expressions which may be dependent on the stages of breast cancer development or different cell types. Here, CDKN2A is linked to breast cancer.